首页 | 本学科首页   官方微博 | 高级检索  
     


RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy
Affiliation:1. Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA;2. Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA;3. Department of Pediatrics (Division of Cardiology), Stanford University School of Medicine, Stanford, CA 94305, USA;4. Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA;5. British Columbia Children’s Hospital Research Institute, Vancouver, BC V5Z 4H4, Canada;6. Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada;7. Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada;8. Pharmaceutical Outcomes Programme, British Columbia Children’s Hospital, Vancouver, BC V5Z 4H4, Canada
Abstract:
><ol class=
  • Download : Download high-res image (159KB)
  • Download : Download full-size image
  • Keywords:doxorubicin  anthracycline  chemotherapy  cardiotoxocity  cardiomyopathy  human induced pluripiotent stem cell  cardiomyocyte  variant  pharmacogenomics  cardioprotection
    本文献已被 ScienceDirect 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号